HOW WE DELIVER PROGRESS
EORTC plays a key role in multi-disciplinary, international translational and clinical research. It takes science from the lab to the patient. EORTC is an independent clinical cancer hub with a unique global research infrastrure that works across tumour types, research disciplines and national boarders, leaving no cancer patient behind.
Its synergistic network of institutions offer researchers a transnational research platform with an unsurpassed level of quality and efficiency, with a special interest in rare cancers and long-term follow-up. EORTC delivers robust data sets and is committed to generate solid medical evidence.
PRACTICE CHANGING RESEARCH
-
Breast Cancer Group
MINDACT study: Using gene signatures to determine optimal treatment in early breast cancer. (EORTC 10041)
Sparing women with early breast cancer from mastectomy. (EORTC 10801)
AMAROS study: Confirming radiation as an effective treatment alternative to surgery, for women with early breast cancer. (EORTC 10981/22023)
- BRAIN
- BREAST
- GENITO-URINARY
- HEAD & NECK
- LYMPHOMA
- MELANOMA
- SOFT TISSUE & BONE SARCOMA
LATEST PUBLICATIONS
Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.
